belantamab mafodotin,anakinra,tocilizumab,idecabtagene vicleucel
sobi,gsk,roche,bms,2seventy bio
['toci', 'mmsm', 'belantamab,mafodotin', 'ide-cel', 'elevate,(-elevate uc),(-elevateuc),(-elevate-uc),(-elevate rr),(-elevaterr),(-elevate-rr),(-elevate tn),(-elevatetn),(-elevate-tn)', 'belantamab', 'tocilizumab', 'anakinra']
congress | #ash22
hamza hashmi , presents real world data suggesting the presence of 2 of either prior bcma-directed exposure, high-risk cytogenetics, or raised ferritin after lymphodepletion negatively impacts survival after ide-cel therapy. #mmsm 
The Multiple Myeloma (MM) Hub is an online educational resource run in collaboration with the European School of Haematology @ESHaematology #mmsm #myeloma